Back to User profile » Dr Xiangying Meng
Papers published by Dr Xiangying Meng:
A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease
Liu C, Sun B, Xu B, Meng X, Li L, Cong Y, Liu J, Wang Q, Xuan L, Song Q, Wu S
Cancer Management and Research 2018, 10:1749-1761
Published Date: 26 June 2018
Albumin/globulin ratio is negatively correlated with PD-1 and CD25 mRNA levels in breast cancer patients
Liu C, Wang W, Meng XY, Sun B, Cong Y, Liu JN, Wang Q, Liu GX, Wu SK
OncoTargets and Therapy 2018, 11:2131-2139
Published Date: 12 April 2018
Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer
Liu C, Huang Z, Wang QS, Sun B, Ding LJ, Meng XY, Wu SK
OncoTargets and Therapy 2016, 9:4653-4660
Published Date: 27 July 2016
Combined treatment with everolimus and fulvestrant reversed anti-HER2 resistance in a patient with refractory advanced breast cancer: a case report
Sun B, Ding LJ, Wu S, Meng XY, Song S
OncoTargets and Therapy 2016, 9:3997-4003
Published Date: 1 July 2016